Home/Filings/4/0001209191-20-030585
4//SEC Filing

Dickinson Klara 4

Accession 0001209191-20-030585

CIK 0001042074other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 5:16 PM ET

Size

5.7 KB

Accession

0001209191-20-030585

Insider Transaction Report

Form 4
Period: 2020-05-15
Dickinson Klara
SVP, Regulatory Affairs & QA
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-05-15+328,299328,299 total
    Exercise: $4.05Exp: 2030-05-14Common Stock (328,299 underlying)
Footnotes (1)
  • [F1]The shares subject to the option shall vest in 48 equal monthly installments commencing on January 31, 2020, subject to the Reporting Person's continuous service to the Issuer as of each such date.

Issuer

CymaBay Therapeutics, Inc.

CIK 0001042074

Entity typeother

Related Parties

1
  • filerCIK 0001339895

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 5:16 PM ET
Size
5.7 KB